HEADER PORTRAITS ARE LO RES...
WAITING ON IMAGES

Every woman deserves

a full journey of care

Reshaping Lives: Full Circle

  • Reshaping Lives: Full Circle is a program launched by Mission Plasticos, a 501-c3 non-profit organization dedicated to providing no-cost reconstructive surgical care to people in the U.S. who are uninsured or underinsured, and  Sientra, a medical aesthetics company focused on plastic surgery. During its first year, additional partners MTF biologicsRestorative Ink Specialists, MiraDry, AnaOno, and AlumierMD have signed on to support the program.

    This program is focused on breast reconstruction surgery for post-mastectomy women living in poverty as part of Reshaping Lives America, the first large-scale nationwide program providing no-cost reconstructive care to U.S. children and adults who are uninsured or underinsured.

    This program highlights Mission Plasticos’ and our partners’ commitment to patients and the community.

Products & Surgeons

    The Reshaping Lives: Full Circle program offer patients in need an opportunity to receive reconstructive care from leading board-certified volunteer plastic surgeons across the country.

    For each Reshaping Lives: Full Circle surgery, Sientra will supply to the surgeons at no cost; Sientra’s state-of-the-art silicone gel breast implants, which have an unrivaled safety profile and are clinically shown to have low complication rates1 ; and their one-of-a-kind breast tissue expanders, which are used to form a new breast pocket that will eventually hold the long-term breast implant.

    Additional partners MTF biologics provide their allograft tissues and Restorative Ink Specialists provide 3D nipple tattooing. Further generous support for the program includes monetary support from MiraDry, custom bras from AnaOno, and skincare products from AlumierMD.

    Reshaping Lives: Full Circle exists through the generosity of our board-certified plastic surgeons who volunteer their time and facilities, our partners, and the donations of companies and individuals who believe every woman deserves a full journey of care.

    • Dermaspan®
    • AlloX2®
    • SientraRoundTM gel implants and
      Sientra TeardropTM Shape Gel Implants

    For more information about Sientra and the Sientra portfolio of breast products visit, Sientra.com/breast-reconstruction

Sientra is proud to support the Mission Plasticos Reshaping Lives America program through our $1 million donation. Connecting patients in need with outstanding board-certified reconstructive surgeons will make a significant difference in the lives of not only patients, but also their families and communities.

Ron Menezes,
Sientra CEO and Reshaping Lives America Council of Trustees Chair

Reshaping Lives America

Council of Trustees
Portrait of Joe Yaccarino Joe Yaccarino MTF Biologics President and Chief Executive Officer | Reshaping Lives America Council of Trustees Chair Portrait of Robert Caitlin Robert Catlin miraDry CEO | Reshaping Lives America Council of Trustees Member Portrait of N. Bill Aydin N. Bill Aydin Aydin Center for Plastic Surgery | Reshaping Lives America Council of Trustees Member Portrait of Natalie Do Natalie Do, DO., Pharm.D. CalOptima Medical Director of Behavioral Health | Reshaping Lives America Council of Trustees Member Portrait of Oliver Burckhardt Oliver Burckhardt Tiger Aesthetics Co-CEO | Reshaping Lives America Council of Trustees Member Portrait of Scott Madden Scott Madden Tiger Aesthetics Co-CEO | Reshaping Lives America Council of Trustees Member Portrait of Arash Khazei Arash Khazei Obagi, President & Chief Financial Officer | Reshaping Lives America Council of Trustees Member
Staff
Portrait of Susan Williamson Susan Williamson Executive Director | Mission Plasticos Portrait of Adriana Murillo Adriana Murillo Program Director | Mission Plasticos
1. Stevens WG, Calobrace MB, Alizadeh A, Zeidler KR, Harrington JL, d’Incelli RC. Ten-year core study data for Sientra’s Food and Drug Administration—approved round and shaped breast implants with cohesive silicone gel. Plast Reconstr Surg. 2018;141(4S):7S-19S